Search results for "OLED"

showing 10 items of 349 documents

Smoking and Helicobacter pylori infection: an individual participant pooled analysis (Stomach Cancer Pooling- StoP Project)

2019

Smoking has been associated with acquisition and increased persistence of Helicobacter pylori infection, as well as with lower effectiveness of its eradication. A greater prevalence of infection among smokers could contribute to the increased risk for gastric cancer. We aimed to estimate the association between smoking and seropositivity to H. pylori through an individual participant data pooled analysis using controls from 14 case- control studies participating in the Stomach Cancer Pooling Project. Summary odds ratios and prevalence ratios (PRs), adjusted for age, sex and social class, and the corresponding 95% confidence intervals (CIs) were estimated through random-effects meta-analysis…

AdultMaleCancer ResearchEpidemiologyPoolingserologyconsortiumRisk AssessmentsmokingHelicobacter Infections03 medical and health sciencesSex Factors0302 clinical medicineRisk FactorsStomach NeoplasmsPrevalenceTobacco SmokingmedicineHumanspooled analysi030212 general & internal medicineStomach cancerAgedSmokersHelicobacter pyloribusiness.industryAge FactorsPublic Health Environmental and Occupational HealthCase-control studyCancerindividual participant dataPublication biasOdds ratioMiddle Agedmedicine.diseaseConfidence intervalOncologyGastric MucosaCase-Control Studies030220 oncology & carcinogenesisFemalebusinessRisk assessmentDemographyEuropean Journal of Cancer Prevention
researchProduct

Sister chromatid exchange in Waldenström's macroglobulinemia

1993

Results on sister chromatid exchange (SCE) frequency and interchromosomal distribution in bone marrow and peripheral blood cultures from patients with Waldenström's macroglobulinemia are reported. PHA-stimulated bone marrow cultures showed increased SCE frequencies in all 12 patients examined. The increase was particularly high in two cases (17.07 and 16.77 SCE/cell, respectively) and, in one of them, a very high SCE level was found in PHA-stimulated peripheral blood culture (40.81 SCE/cell). In LPS-stimulated cultures, increased SCE levels were observed in some patients. Comparison between SCE frequency in bone marrow cell cultures with either mitogen showed a significant increase in PHA-s…

AdultMaleCancer ResearchG chromosomeCellSister chromatid exchangeBiologyGeneticsmedicineHumansPooled dataMolecular BiologyAgedCell CycleMacroglobulinemiaWaldenstrom macroglobulinemiaMiddle AgedCell cyclemedicine.diseaseMolecular biologySettore BIO/18 - Geneticamedicine.anatomical_structureImmunologySister chromatid exchanges Waldenstrom's macroglobulinemiaFemaleBone marrowWaldenstrom MacroglobulinemiaSister Chromatid ExchangeCancer Genetics and Cytogenetics
researchProduct

Non-Hodgkin lymphoma and obesity: A pooled analysis from the InterLymph consortium

2008

Nutritional status is known to alter immune function, a suspected risk factor for non-Hodgkin lymphoma (NHL). To investigate whether long-term over, or under, nutrition is associated with NHL, self-reported anthropometric data on weight and height from over 10,000 cases of NHL and 16,000 controls were pooled across 18 case-control studies identified through the International Lymphoma Epidemiology Consortium. Study-specific odds ratios (OR) were estimated using logistic regression and combined using a random-effects model. Severe obesity, defined as BMI of 40 kg m-2 or more, was not associated with NHL overall (pooled OR = 1.00, 95% confidence interval (CI) 0.70-1.41) or the majority of NHL …

AdultMaleCancer Researchmedicine.medical_specialtyInternational CooperationOverweightRisk AssessmentArticleBody Mass IndexRisk FactorsInternal medicinehemic and lymphatic diseasesEpidemiologyOdds RatiomedicineHumansObesityRisk factorAgedbusiness.industryLymphoma Non-HodgkinBody WeightNon-Hodgkin lymphoma obesity pooled analysis InterLymph consortiumOdds ratioMiddle Agedmedicine.diseaseObesityBody HeightConfidence intervalSurgeryOncologyFemaleLymphoma Large B-Cell Diffusemedicine.symptomUnderweightbusinessBody mass index
researchProduct

Surgery-triggered and non surgery-triggered Bisphosphonate-related Osteonecrosis of the Jaws (BRONJ): A retrospective analysis of 567 cases in an Ita…

2011

Invasive local procedures are often reported in clinical history of patients suffering from Bisphosphonates-Related Osteonecrosis of the Jaws (BRONJ) but over 40% of spontaneous forms have been also described in literature. We compared age, gender, underlying bone disorders, bisphosphonate therapy, clinical features and surgical outcome of 205 cases (36.2%) of BRONJ non surgery-triggered (group 1) with 362 (63.8%) cases of surgery-triggered forms (group 2). Differences between group 1 and 2 were analysed using Mann-Whitney U and χ2 tests. Statistical analysis was performed using STATA 8. Zoledronate was the most used type of bisphosphonate (63.4% versus 69.0%) and the mandible was the most …

AdultMaleCancer Researchmedicine.medical_specialtyTooth extractionmedicine.medical_treatmentZoledronic AcidSettore MED/28 - Malattie OdontostomatologicheRisk FactorsClinical historySpontaneous formmedicineRetrospective analysisHumansStatistical analysisStage (cooking)AgedRetrospective StudiesAged 80 and overSurgical outcomeBone Density Conservation AgentsDiphosphonatesBRONJOrthognathic Surgical Proceduresbusiness.industryImidazolesOsteonecrosisBisphosphonates-related Osteonecrosis of the JawMiddle AgedBisphosphonateSurgeryZoledronic acidItalyOncologyMulticenter studyFemaleBisphosphonate therapyOral SurgerybusinessJaw Diseasesmedicine.drugOral Oncology
researchProduct

High constant incidence rates of second primary cancers of the head and neck: a pooled analysis of 13 cancer registries

2010

Scanty data are available on the incidence (i.e., the absolute risk) of second cancers of the head and neck (HN) and its pattern with age. We investigated this issue using data from a multicentric study of 13 population-based cancer registries from Europe, Canada, Australia and Singapore for the years 1943-2000. A total of 99,257 patients had a first primary HN cancer (15,985 tongue, 22,378 mouth, 20,758 pharyngeal, and 40,190 laryngeal cancer), contributing to 489,855 person-years of follow-up. 1294 of the patients (1.3%) were diagnosed with second HN cancers (342 tongue, 345 mouth, 418 pharynx, and 189 larynx). Male incidence rates of first HN cancer steeply increased from 0.68/100,000 at…

AdultMaleLarynxOncologyCancer Researchmedicine.medical_specialtyPopulationArticlehead and neckTongueInternal medicineEpidemiologymedicineHumanscancerpooled analysiRegistrieseducationAgedAged 80 and overGynecologyeducation.field_of_studybusiness.industryIncidence (epidemiology)second neoplasmsHead and neck cancerPharynxCancerNeoplasms Second PrimaryMiddle Agedmedicine.diseasesecond primaryAdult ; Aged ; Aged 80 and over ; Female ; Head and Neck Neoplasms/epidemiology* ; Humans ; Incidence ; Male ; Middle Aged ; Neoplasms Second Primary/epidemiology*; Registriesmedicine.anatomical_structureOncologyageHead and Neck Neoplasmscancer registriesincidenceFemalehead and neck cancerHigh constant incidence ratebusiness
researchProduct

Clinicopathologic features of nasopalatine duct cysts: A retrospective study in two Brazilian oral and maxillofacial pathology referral centers

2021

Background Nasopalatine duct cyst (NDC) is the most common non-odontogenic cyst in the oral cavity. Clinically it is not difficult to suspect these lesions based on clinical and radiographic appearance. However, the histopathological diagnosis may be difficult due to the broad morphological diversity of these lesions. The objective was to analyze the clinicopathological features of NDCs diagnosed in two oral and maxillofacial pathology services in the Brazilian northeast. Material and Methods A retrospective clinicopathologic study was performed. A total of 18,121 clinical records of oral lesions from two oral and maxillofacial pathology services in Brazil were analyzed (2000-2020). All NDC…

AdultMalePathologymedicine.medical_specialtyrecurrenceRadiographyStratified squamous epitheliumAsymptomaticzoledronic acidOral and maxillofacial pathologyNasopalatine duct cystMedicineHumansCystbisphosphonatesplatelet rich plasmaGeneral DentistryReferral and ConsultationUNESCO:CIENCIAS MÉDICASRetrospective StudiesOral Medicine and Pathologybusiness.industryCystsResearchdenosumabRetrospective cohort studymedicine.diseaseNonodontogenic Cystsosteonecrosis of the jawmedicine.anatomical_structurerisk factorOtorhinolaryngologyGiant cellPathology OralSurgeryFemalemedicine.symptombusinessBrazilMedicina Oral, Patología Oral y Cirugía Bucal
researchProduct

Treatment of acute venous thromboembolism with dabigatran or warfarin and pooled analysis

2014

Background— Dabigatran and warfarin have been compared for the treatment of acute venous thromboembolism (VTE) in a previous trial. We undertook this study to extend those findings. Methods and Results— In a randomized, double-blind, double-dummy trial of 2589 patients with acute VTE treated with low-molecular-weight or unfractionated heparin for 5 to 11 days, we compared dabigatran 150 mg twice daily with warfarin. The primary outcome, recurrent symptomatic, objectively confirmed VTE and related deaths during 6 months of treatment occurred in 30 of the 1279 dabigatran patients (2.3%) compared with 28 of the 1289 warfarin patients (2.2%; hazard ratio, 1.08; 95% confidence interval [CI], 0.…

AdultMalemedicine.medical_specialtyRE-COVER IIrecurrenceAntagonists & inhibitorsAdolescentvenous thromboembolismAntithrombinsDabigatranYoung AdultDouble-Blind MethodRisk FactorsPhysiology (medical)Internal medicinemedicineHumansdabigatrancardiovascular diseasesantagonists & inhibitorAgedacute venous thromboembolismHeparinbusiness.industryWarfarinFollow up studiesAnticoagulantsantagonists & inhibitors; hemorrhage; recurrence; thrombin; venous thromboembolism; warfarinHeparinHeparin Low-Molecular-WeightMiddle AgedthrombinSettore MED/11 - Malattie Dell'Apparato CardiovascolarewarfarinHeparin.low molecular weightPooled analysisAnesthesiaAcute Diseasebeta-AlanineBenzimidazolesFemaledabigatran; warfarin; acute venous thromboembolism; RE-COVER IIhemorrhageCardiology and Cardiovascular MedicinebusinessVenous thromboembolismFollow-Up Studiesmedicine.drug
researchProduct

Single-incision laparoscopic cholecystectomy: Our experience and review of literature

2016

Aim After the revolution in the surgery of gallbladder stones represented by the laparoscopic cholecystectomy, we tried a new technique that further maximize the aesthetic results and that at the same time is of easy learning for young surgeons. Patients and methods From January 2011 to December 2012 we performed at our department 320 cholecystectomy: 27 in laparotomy and 293 in laparoscopy. Of these, 88 underwent to Single Incision Laparoscopic Surgery (SILS), namely the Single Incision Laparoscopic Cholecystectomy (SILC), in recruited patients aged between 19-65 years; 56 patients were females and 32 were males. Results The laparoscopic cholecystectomy with the SILS methodology is a safe …

AdultMalemedicine.medical_specialtymedicine.medical_treatmentGallstonesUmbilical painYoung AdultLaparotomymedicineHumansCholecystectomyLaparoscopyLaparoscopic cholecystectomySingle port; Cholecystectomy; Cholecysto-choledochal lithiasis; SILSSILSAgedmedicine.diagnostic_testbusiness.industryCholecysto-choledochal lithiasiGeneral surgeryGallstonesMini-ReviewMiddle Agedmedicine.diseaseUmbilical herniaSingle incision laparoscopicCholecystectomy LaparoscopicGallstoneCholecysto-choledochal lithiasisCholecystectomyFemalebusinessSingle portHuman
researchProduct

Effects of zoledronic acid on proteinase plasma levels in patients with bone metastases.

2006

Background: The effects of the bisphosphonate derivative zoledronic acid (ZA) on the > circulating levels of matrix metalloproteinase-2 (MMP-2), matrix metallo-proteinases-9 > (MMP-9), cathepsin B (Cath B) and urokinase-type plasminogen activator (uPA) in > patients with bone metastasis (BMTS) and the possible correlation with the symptomatic > response induced by this drug in these patients were evaluated. Patients and Methods: > Proteinase levels were determined by enzyme-linked immunosorbent assay (ELISA) in the > plasma of 30 patients with painful bone metastases from breast or prostate cancer > undergoing multiple treatment with ZA (4 mg i.v., every 4 weeks). Healthy subjects > (HS) of…

Aged 80 and overMaleBone Density Conservation AgentsDiphosphonatesZoledronic > acidImidazolesProstatic NeoplasmsBone NeoplasmsBreast NeoplasmsMiddle AgedProteinaseZoledronic AcidCathepsin BMatrix > metalloproteinase-9Matrix Metalloproteinase 9Matrix metalloproteinase-2Bone metastasiBisphosphonates; Bone metastasis; Cathepsin B; Matrix metalloproteinase-2; Matrix > metalloproteinase-9; Proteinases; Urokinase-type plasminogen activator; Zoledronic > acidHumansMatrix Metalloproteinase 2BisphosphonateFemaleUrokinase-type plasminogen activatorAged
researchProduct

Mujer, poder político y democracia paritaria. “Mujer y representación política institucional en la Comunidad Valenciana. 1977-1995. 2 parte.

2014

Mujer, poder político y democracia paritaria. “Mujer y representación política institucional en la Comunidad Valenciana. 1977-1995. 2 parte. En esta segunda parte se recogen las mujeres que han formado parte de la Administración Local (alcaldesas, diputadas provinciales y FVMP), en los sindicatos, asi como en otras instituciones: Consell Valencià de Cultura, Consejo de Radiotelevisión Valenciana, Sindicatura de Agravios, Academia Valenciana de la Lengua, universidades, direcciones de partidos políticos, y otras organizaciones de la Comunidad Valenciana. “Mujer y representación política institucional en la Comunidad Valenciana. 1977-1995. Diputadas, ministras y cargos institucionales” es la …

Alcaldesas de la Comunidad Valenciana. Clementina Rodenas Villena. Rita Barberá Nolla. Josefa Mateu. Rosa Mazón. Carmen Gimeno. María Cabanes. Vicenta Bosch Palanca. Josefa Mateu. Violeta Rivera. Rosa Mengual. Empar Navarro i Prosper. Celeste García Estarlich. Mª. Dolores Botella Arbona. Carmen Martínez Ramírez. Gloria Isabel Calero Albal. Francisca R. Viciano Guillem. Teresa Parra Almiñana. Vicenta Tortosa Urrea. Rosa Maria Verdú Ramos. Mª. Milagrosa Martínez Navarro. Ana Noguera. María Ángeles Crespo Martínez. María Emma Iranzo Martín. Amparo Belmonte Burgos. María Ángeles Crespo Martínez. Lina Insa Rico. Teresa Ballester Artigues. Elena María Bastidas Bono. Mª. Elena Albentosa Ruso. María Rosa Verdú Alonso. María José Torres Amorós. María José García Herrero. Antonia Martínez Soler. Mª del Carmen Martínez Clemor. Enriqueta Seller Roca de Togores. Juliana González Maillo. Mercedes Alonso García. Mª de los Frutos Barceló La Torre. Luisa Pastor Lillo. Mª Antonieta Carratalá Aracil. María del Carmen Jiménez Egea. María Milagros Diego Martínez. Ana María Kringe Sánchez. Josefa Martín Bru. Luisa Pastor Lillo. María Gloria Pérez Martínez. María Teresa Sempere Juan. María Teresa Carbonell Bernabeu. María Loreto Martínez Ramos. Alicia Vázquez Fernández. Carmen García-Fuster y González-Alegre. Encarna Lerma Blasco. Francisca Gimeno Mocholi.Concha Martínez Romero. María A. Crespo Martínez. Gloria Arnandis Boix. Rosa Isabel Ribes Abel. Margarita Pin Arboledas. Nuria Espí de Navas. Purificación Martí Fenollosa. Asunción Quinzá Alegre. María Consuelo Orias Gonzalvo. Ascensión Figueres Górriz. María Remedios Vila Castelló. Mª Luisa Oliver Mallasén. Herminia Palomar Pérez. María Teresa Sidro. Carmina Martinavarro Moya. Consuelo Sanz Molés. Concepción Saenz Laín. Gobernadora civil de Castellón. Carmen Moya García delegada del Gobierno en la Comunidad Valenciana. Carmen Mas Rubio delegada del Gobierno en la Comunidad Valenciana. Pilar Brabo. Dulce Contreras Isabel Segura Maria Antonia García Benau. Cristina Santamaría Siurana. Isabel Morant. Adela Cortina. Neus Campillo. Trinidad Simó. Remedios Sánchez entre otras. Irene Abad Miró. María Francisca Abad García. Mari Luz Terradas. Amparo Caballer Cabo.Foro de Opinión. María Dolores Vilanova Alonso. Amparo Llop. María José Reyes. Mariló Pla. Cristina Piris. Victoria Prades. Mari Luz Marco. Julia Carles. Elisa Cabanes. Magarita Sanz Alonso. Ofelia Vila Hernández. Carme Morenilla i Talens. Rosa Mª Magdalena Rodríguez Pérez. Rosa Serrano Llácer. Síndic de Greuges de la Comunidad Valenciana. Julia Sevilla Merino. Emilia Caballero Álvarez. Ascensión Figueres Górriz. Carmen Barceló Torres. Verónica Cantó Doménech. Maria Soledad González Felip. Amàlia Alba Tarazona. Dones Progressistes. Susana Camarero Benitez. Macarena Montesinos. Marcela Miró Pérez. Pepa Chesa. Mª Josep Amigó. Teresa Blat. Lobby Europeo de Mujeres. Rosa Solbes. Inmaculada Serra Yoldi.:CIENCIA POLÍTICA [UNESCO]UNESCO::CIENCIA POLÍTICA
researchProduct